Akèy › Anplwayè › Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc.: Salè H-1B ak pajon
Longboard Pharmaceuticals, Inc. depoze 3 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 3. Medyèn salè yo ofri a: $164,674.
Èske Longboard Pharmaceuticals, Inc. pajone visa H-1B?
Longboard Pharmaceuticals, Inc. depoze 3 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Oct 7, 2024. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Senior Global Clinical Trial Lead | 1 | $164,674 |
| Sr. Manager/Associate Director, Drug Safety Operations | 1 | $157,435 |
| Director, Drug Safety Operations | 1 | $207,979 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2024 | 2 | $161,054 |
| FY2025 | 1 | $207,979 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Director, Drug Safety Operations | $207,979–$236,213 Nivo III | La Jolla, CA | Oct 7, 2024 | Oct 21, 2024 | Certifye |
| Sr. Manager/Associate Director, Drug Safety Operations | $157,435–$180,000 Nivo II | Newbury Park, CA | Aug 23, 2024 | Sep 9, 2024 | Certifye, apre retire |
| Senior Global Clinical Trial Lead | $164,674–$206,800 E-3 · Nivo II | Manhattan, NY | May 15, 2024 | Jul 1, 2024 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).